Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods
Inhibitori angiotenzin - konvertujućeg enzima - osnovne farmakološke osobine i metode određivanja
Abstract
Angiotensin-converting enzyme inhibitors (ACE inhibitors) lower blood pressure, reduce morbidity and mortality in patients with heart failure, decrease mortality and the incidence of heart failure in patients with myocardial infarction and preserve kidney function in diabetic and non-diabetic patients. Even though they belong to the same group of drugs and have similar efficacy, ACE inhibitors exhibit different pharmacological characteristics. Furthermore, different methods for their determination are used in practice.
Inhibitori angiotenzin - konvertujućeg enzima (ACE inhibitori) su lekovi izbora u lečenju hipertenzije, što ih svrstava među najčešće propisivane lekove u praksi. Primenjuju se i u lečenju srčane insuficijencije, infarkta miokarda i bubrežne slabosti dijabetesne i nedijabetesne etiologije. Iako pripadaju istoj grupi lekova i pokazuju sličnu kliničku efikasnost, pojedini ACE inhibitori imaju različite farmakološke osobine, a u praksi se koriste različite metode za njihovo određivanje.
Keywords:
angiotensin-converting enzyme inhibitors / high performance liquid chromatography / thin-layer chromatography / spectrophotometry / spectrofluorimetry / inhibitori angiotenzin-konvertujućeg enzima (ACE inhibitori) / visoko efikasna tečna hromatografija / tankoslojna hromatografija / spektrofotometrija / spektrofluorimetrijaSource:
Arhiv za farmaciju, 2009, 59, 1, 27-39Publisher:
- Savez farmaceutskih udruženja Srbije, Beograd
Collections
Institution/Community
PharmacyTY - JOUR AU - Odović, Jadranka AU - Aleksić, Mirjana AU - Trbojević-Stanković, Jasna PY - 2009 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1301 AB - Angiotensin-converting enzyme inhibitors (ACE inhibitors) lower blood pressure, reduce morbidity and mortality in patients with heart failure, decrease mortality and the incidence of heart failure in patients with myocardial infarction and preserve kidney function in diabetic and non-diabetic patients. Even though they belong to the same group of drugs and have similar efficacy, ACE inhibitors exhibit different pharmacological characteristics. Furthermore, different methods for their determination are used in practice. AB - Inhibitori angiotenzin - konvertujućeg enzima (ACE inhibitori) su lekovi izbora u lečenju hipertenzije, što ih svrstava među najčešće propisivane lekove u praksi. Primenjuju se i u lečenju srčane insuficijencije, infarkta miokarda i bubrežne slabosti dijabetesne i nedijabetesne etiologije. Iako pripadaju istoj grupi lekova i pokazuju sličnu kliničku efikasnost, pojedini ACE inhibitori imaju različite farmakološke osobine, a u praksi se koriste različite metode za njihovo određivanje. PB - Savez farmaceutskih udruženja Srbije, Beograd T2 - Arhiv za farmaciju T1 - Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods T1 - Inhibitori angiotenzin - konvertujućeg enzima - osnovne farmakološke osobine i metode određivanja VL - 59 IS - 1 SP - 27 EP - 39 UR - https://hdl.handle.net/21.15107/rcub_farfar_1301 ER -
@article{ author = "Odović, Jadranka and Aleksić, Mirjana and Trbojević-Stanković, Jasna", year = "2009", abstract = "Angiotensin-converting enzyme inhibitors (ACE inhibitors) lower blood pressure, reduce morbidity and mortality in patients with heart failure, decrease mortality and the incidence of heart failure in patients with myocardial infarction and preserve kidney function in diabetic and non-diabetic patients. Even though they belong to the same group of drugs and have similar efficacy, ACE inhibitors exhibit different pharmacological characteristics. Furthermore, different methods for their determination are used in practice., Inhibitori angiotenzin - konvertujućeg enzima (ACE inhibitori) su lekovi izbora u lečenju hipertenzije, što ih svrstava među najčešće propisivane lekove u praksi. Primenjuju se i u lečenju srčane insuficijencije, infarkta miokarda i bubrežne slabosti dijabetesne i nedijabetesne etiologije. Iako pripadaju istoj grupi lekova i pokazuju sličnu kliničku efikasnost, pojedini ACE inhibitori imaju različite farmakološke osobine, a u praksi se koriste različite metode za njihovo određivanje.", publisher = "Savez farmaceutskih udruženja Srbije, Beograd", journal = "Arhiv za farmaciju", title = "Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods, Inhibitori angiotenzin - konvertujućeg enzima - osnovne farmakološke osobine i metode određivanja", volume = "59", number = "1", pages = "27-39", url = "https://hdl.handle.net/21.15107/rcub_farfar_1301" }
Odović, J., Aleksić, M.,& Trbojević-Stanković, J.. (2009). Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods. in Arhiv za farmaciju Savez farmaceutskih udruženja Srbije, Beograd., 59(1), 27-39. https://hdl.handle.net/21.15107/rcub_farfar_1301
Odović J, Aleksić M, Trbojević-Stanković J. Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods. in Arhiv za farmaciju. 2009;59(1):27-39. https://hdl.handle.net/21.15107/rcub_farfar_1301 .
Odović, Jadranka, Aleksić, Mirjana, Trbojević-Stanković, Jasna, "Angiotensin - converting enzyme inhibitors: Basic pharmacological properties and determination methods" in Arhiv za farmaciju, 59, no. 1 (2009):27-39, https://hdl.handle.net/21.15107/rcub_farfar_1301 .